Trial Information
TARGeted Intraoperative radioTherapy With the INTRABEAM-System as an Advanced Boost in Patients With Breast Cancer - A Quality Control Registry in Germany (TARGIT BQR)
Inclusion Criteria:
- Tumor diameter < 3,5 cm
- Informed consent
Exclusion Criteria:
- No informed consent
- Tumor size > 3,5 cm
- No indication for a boost
Type of Study:
Observational
Study Design:
Observational Model: Ecologic or Community, Time Perspective: Prospective
Outcome Measure:
Local recurrence rate
Outcome Time Frame:
5 years
Safety Issue:
Yes
Principal Investigator
Frederik Wenz, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Hospital Mannheim
Authority:
Germany: Ethics Commission
Study ID:
TARGIT BQR
NCT ID:
NCT01440010
Start Date:
September 2011
Completion Date:
Related Keywords:
- Breast Cancer
- IORT
- Boost
- Breast cancer
- Local recurrence
- Toxicity
- LENT SOMA
- TARGIT
- Quality Control Registry
- Breast Neoplasms